Innovative therapeutic strategies against cancer, (epi)drug discovery and development, identification of pathogenesis of diseases with a focus on cancer (epi)genome alterations. Her contribution to the understanding of chromatin deregulation and epi-biomarkers in cancer as well as to the identification of innovative epi-strategies for cancer treatment and prevention are considered relevant. Co-Editor in chief role in the Clinical Epigenetics (Springer Nature). Co-Editor in chief in the Epigenetics Communications (Springer Nature).